Becton Dickinson lands in Morristown after a short hop from Dulles

Becton Dickinson flew from Washington Dulles International Airport to Morristown Municipal Airport on June 4, 2026, a flight that lasted barely long enough to reach 1,300 feet before descending. The 115-knot hop covered roughly 200 miles, suggesting a quick turn or a repositioning rather than a cross-country journey.

The same week, per an FDA docket update on June 3, the agency is reviewing Becton Dickinson’s premarket submission for a new sepsis diagnostic panel, a product the company has flagged as a key growth driver in its 2026 investor materials. The Dulles departure likely reflects meetings with regulators or lawmakers on Capitol Hill, a common pattern for the Franklin Lakes-based firm when it has a submission under active review.

Becton Dickinson’s recent flight history shows a heavy Northeast corridor rhythm—Chicago, Boston, Providence, and back to Morristown—consistent with CEO Tom Polen’s stated focus on hospital-system sales and FDA engagement. This trip, a brief Washington-to-home hop, fits the quiet, business-as-usual cadence of a company that lives and dies by regulatory calendars.